SE Come

878 total citations
19 papers, 652 citations indexed

About

SE Come is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, SE Come has authored 19 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in SE Come's work include Advanced Breast Cancer Therapies (7 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (3 papers). SE Come is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (3 papers). SE Come collaborates with scholars based in United States, Israel and Canada. SE Come's co-authors include Isaiah W. Dimery, Aman U. Buzdar, John Pippen, L M Parker, Richard Elledge, Charles Morris, Alan Webster, S. Gertler, Matthew J. Ellis and G. Burton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

SE Come

19 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SE Come United States 8 429 355 288 249 103 19 652
E. Jane Macaskill United Kingdom 12 329 0.8× 232 0.7× 244 0.8× 130 0.5× 133 1.3× 18 533
M. Azab United Kingdom 6 547 1.3× 390 1.1× 303 1.1× 228 0.9× 156 1.5× 7 845
Roberto Torres Chile 8 570 1.3× 302 0.9× 280 1.0× 532 2.1× 127 1.2× 20 799
William N. Harwin United States 7 488 1.1× 535 1.5× 395 1.4× 259 1.0× 129 1.3× 21 856
Juliette Murray United Kingdom 11 312 0.7× 275 0.8× 276 1.0× 90 0.4× 137 1.3× 27 532
J.P. Lobelle Belgium 12 521 1.2× 294 0.8× 343 1.2× 117 0.5× 134 1.3× 25 794
Oliver Young United Kingdom 10 351 0.8× 311 0.9× 298 1.0× 106 0.4× 145 1.4× 17 578
Mikael von Euler Sweden 6 255 0.6× 337 0.9× 257 0.9× 137 0.6× 108 1.0× 12 531
Sally Garnett United Kingdom 9 614 1.4× 340 1.0× 269 0.9× 544 2.2× 147 1.4× 12 847
Joern Hilfrich Germany 5 463 1.1× 491 1.4× 407 1.4× 119 0.5× 63 0.6× 11 731

Countries citing papers authored by SE Come

Since Specialization
Citations

This map shows the geographic impact of SE Come's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SE Come with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SE Come more than expected).

Fields of papers citing papers by SE Come

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SE Come. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SE Come. The network helps show where SE Come may publish in the future.

Co-authorship network of co-authors of SE Come

This figure shows the co-authorship network connecting the top 25 collaborators of SE Come. A scholar is included among the top collaborators of SE Come based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SE Come. SE Come is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tamimi, RM, et al.. (2019). Abstract GS6-06: Local therapy and quality of life outcomes in young women with breast cancer. Cancer Research. 79(4_Supplement). GS6–6. 3 indexed citations
2.
Mayer, Erica L., Angela DeMichele, Hope S. Rugo, et al.. (2019). A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma. Annals of Oncology. 30(9). 1514–1520. 11 indexed citations
3.
DeMichele, A., KD Miller, HS Rugo, et al.. (2018). Abstract PD5-06: Adjuvant palbociclib plus endocrine therapy for hormone receptor positive/HER2 negative breast cancer: A phase II feasibility study. Cancer Research. 78(4_Supplement). PD5–6. 1 indexed citations
4.
Partridge, AH, et al.. (2016). Abstract P4-10-04: Employment trends in young women following a breast cancer diagnosis. Cancer Research. 76(4_Supplement). P4–10. 2 indexed citations
5.
Seah, Davinia, Julie Najita, Thomas H. Openshaw, et al.. (2013). Attitudes of patients with metastatic breast cancer toward research biopsies. Annals of Oncology. 24(7). 1853–1859. 24 indexed citations
6.
Yelensky, Roman, Gilles Buchwalter, Funda Meric‐Bernstam, et al.. (2013). Abstract S3-06: Emergence of constitutively active estrogen receptor mutations in advanced estrogen receptor positive breast cancer. Cancer Research. 73(24_Supplement). S3–6. 1 indexed citations
7.
Isakoff, SJ, Paul E. Goss, Erica L. Mayer, et al.. (2011). TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response.. Journal of Clinical Oncology. 29(15_suppl). 1025–1025. 30 indexed citations
8.
Collins, LC, Shari Gelber, Sandra Kereakoglow, et al.. (2011). P4-11-12: Molecular Phenotype of Breast Cancers in a Large Cohort of Young Women According to Time Interval Since Pregnancy.. Cancer Research. 71(24_Supplement). P4–11. 12 indexed citations
9.
Sepucha, Karen, J Hirshfield-Bartek, Susan L. Troyan, et al.. (2011). P4-11-10: Perceptions, Knowledge and Satisfaction with Contralateral Prophylactic Mastectomy among Young Women with Breast Cancer.. Cancer Research. 71(24_Supplement). P4–11. 2 indexed citations
10.
Cigler, Tessa, Jackie Szymonifka, A. H. Partridge, et al.. (2011). A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.. Journal of Clinical Oncology. 29(15_suppl). 559–559. 1 indexed citations
11.
Ruddy, Kathryn J., Shari Gelber, Rulla M. Tamimi, et al.. (2011). Fertility concerns in young women with breast cancer: Results from a prospective cohort study.. Journal of Clinical Oncology. 29(15_suppl). 6025–6025. 3 indexed citations
12.
Ruddy, Kathryn J., RM Tamimi, Lidia Schapira, et al.. (2010). Coping strategies in young women with breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 9159–9159. 2 indexed citations
13.
Gelber, Shari, Rulla M. Tamimi, Erica L. Mayer, et al.. (2009). Prevalence and Predictors of Distress in Young Women with Newly Diagnosed Early Stage Breast Cancer.. Cancer Research. 69(24_Supplement). 1067–1067. 1 indexed citations
14.
15.
16.
Bellon, Jennifer R., SE Come, Rebecca Gelman, et al.. (2001). Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Radiation Oncology*Biology*Physics. 51(3). 2–3. 29 indexed citations
17.
Howell, Anthony, C. Kent Osborne, J.F.R. Robertson, et al.. (2001). ICI 182,780 (Faslodex™) versus anastrozole (Arimidex™) for the treatment of advanced breast cancer in postmenopausal women — prospective combined analysis of two multicenter trials. European Journal of Cancer. 37. S151–S151. 10 indexed citations
18.
Recht, Abram, SE Come, Barbara Silver, et al.. (1995). 14 Sequencing of chemotherapy (CT) and radiotherapy (RT) following conservative surgery (CS) for patients with early-stage breast cancer: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 32. 148–148. 7 indexed citations
19.
Henderson, I. Craig, Daniel F. Hayes, SE Come, Jay R. Harris, & George P. Canellos. (1987). New agents and new medical treatments for advanced breast cancer.. PubMed. 14(1). 34–64. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Jane Macaskill Breakdown of academic impact, for papers by M. Azab Breakdown of academic impact, for papers by Roberto Torres Breakdown of academic impact, for papers by William N. Harwin Breakdown of academic impact, for papers by Juliette Murray Breakdown of academic impact, for papers by J.P. Lobelle Breakdown of academic impact, for papers by Oliver Young Breakdown of academic impact, for papers by Mikael von Euler Breakdown of academic impact, for papers by Sally Garnett Breakdown of academic impact, for papers by Joern Hilfrich
Rankless by CCL
2026